J. Wijnen

E. Dekker, J. Kleibeuker, F. Nagengast, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Value-based healthcare in Lynch syndrome

R. Tollenaar, D. Hommes, C. Asperen, 2013, Familial Cancer.

Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

A. Wagner, H. Morreau, M. Breuning, 2006, Gastroenterology.

CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

L. Kiemeney, B. Balliu, J. Houwing-Duistermaat, 2013, European Journal of Human Genetics.

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

M. Blok, C. J. Asperen, G. Matthijs, 2012, Breast Cancer Research and Treatment.

BMC Cancer

Leila Mohammadi, Peter Devilee, H. V. van Houwelingen, 2001 .

Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer

R. Scott, A. Lindblom, J. Lubiński, 2016 .

Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers

J. Houwing-Duistermaat, S. Verhoef, A. Wagner, 2016, Familial Cancer.

The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients

R. Scott, A. Spigelman, B. Talseth-Palmer, 2013, Hereditary cancer in clinical practice.

Enrichment of Low Penetrance Susceptibility Loci in a Dutch Familial Colorectal Cancer Cohort

J. Houwing-Duistermaat, R. Houlston, P. Devilee, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures

H. Meijers-Heijboer, A. Wagner, M. Kriege, 2005, Familial Cancer.

Deciphering the genetics of hereditary non-syndromic colorectal cancer

P. Broderick, J. Vijayakrishnan, K. Sullivan, 2008, European Journal of Human Genetics.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer

David Evans, R. Scott, D. Evans, 2016 .

Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study

A. Lindblom, J. Lubiński, M. Miyaki, 2002, International Journal of Colorectal Disease.

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree

A. Zwinderman, R. Hofstra, A. Wagner, 2001, Journal of medical genetics.

Germ Line Mutations of Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Patients with Small Bowel Cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study

A. Viel, J. Burn, M. Greenblatt, 2006, Clinical Cancer Research.

A procedure for the detection of linkage with high density SNP arrays in a large pedigree with colorectal cancer

J. Houwing-Duistermaat, P. Devilee, H. Morreau, 2007, BMC Cancer.

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

W. Chung, R. Nussbaum, F. Couch, 2016, Breast Cancer Research and Treatment.

Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

D. Altshuler, P. Fasching, P. Hall, 2013, PLoS genetics.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012, Breast Cancer Research.

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS Genetics.

Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer.

K. Heimdal, P. Møller, E. Kure, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours

K. Heimdal, P. Møller, A. Lindblom, 2004, Familial Cancer.

Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry

P. Møller, R. Fodde, W. Müller, 2004, Familial Cancer.

An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1

P. Hutter, W. Foulkes, I. Thiffault, 2002, Journal of medical genetics.

An MLH 1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH 1

P. Hutter, W. Foulkes, I. Thiffault, 2002 .

Electrophoretic characterization and genetics of human biliverdin reductase (BLVR; EC 1.3.1.24); assignment of BLVR to the p14 → cen region of human chromosome 7 in mouse-human somatic cell hybrids

K. Grzeschik, J. Wijnen, P. Meera Khan, 1983, Biochemical Genetics.

Copy number variation analysis and targeted NGS in 77 families with suspected Lynch syndrome reveals novel potential causative genes

P. Bork, T. Doerks, S. Moebus, 2018, International journal of cancer.

Prevalence and molecular heterogeneity of alfa+thalassemia in two tribal populations from Andhra Pradesh, India

R. Fodde, M. Losekoot, M. Oldenburg, 1988, Human Genetics.

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.

P. Møller, A. Lindblom, A. Wagner, 2015, Journal of Clinical Oncology.

Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

A. de la Chapelle, H. Meijers-Heijboer, A. Wagner, 2003, American journal of human genetics.

Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation

H. Meijers-Heijboer, A. Wagner, H. Vasen, 2002, Journal of medical genetics.

Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

P. Møller, H. Meijers-Heijboer, G. Kenter, 2000, The Journal of pathology.

The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers

P. Møller, O. Dekkers, A. Lindblom, 2015, Genetics in Medicine.

Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

R. Vossen, I. Tomlinson, B. Wolffenbuttel, 2017, British Journal of Cancer.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report

P. Møller, E. Hovig, S. Nakken, 2017, Hereditary cancer in clinical practice.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database

P. Møller, E. Hovig, S. Nakken, 2016, Gut.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report

P. Møller, E. Hovig, S. Nakken, 2017, Hereditary Cancer in Clinical Practice.

Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review

E. Kampman, R. Sijmons, C. Tops, 2013, Familial Cancer.

Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of lynch syndrome patients

A. Green, P. Devilee, A. Wagner, 2010, Human mutation.

Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.

A. van der Eb, M. Oldenburg, J. Wijnen, 1987, Nucleic acids research.

Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion

H. Tanke, F. Miedema, R. Willemze, 2002 .

Long‐term follow‐up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion

H. Tanke, F. Miedema, R. Willemze, 2002, British journal of haematology.

Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas

H. Morreau, H. Vasen, C. Tops, 2008, Familial Cancer.

Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.

Inge, J. Kleibeuker, D. Lindhout, 1995, American journal of human genetics.

Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation

H. Putter, M. Schilham, J. Dongen, 2010, Leukemia.

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance

P. Møller, E. Hovig, S. Nakken, 2018 .

DGGE polymorphism in intron 10 of MSH2, the HNPCC gene.

R. Fodde, J. Wijnen, P. Khan, 1994, Human molecular genetics.

Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps

E. Kampman, R. Sijmons, C. Tops, 2013 .

Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy

A. Lindblom, G. Evans, J. Mathers, 2010, Hereditary Cancer in Clinical Practice.

Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach

R. Fodde, J. Burn, M. Cravo, 2000, European Journal of Human Genetics.

Prostate cancer is part of the hereditary non‐polyposis colorectal cancer (HNPCC) tumor spectrum

P. Hutter, R. Fodde, J. Blouin, 2003, American journal of medical genetics. Part A.

Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non‐polyposis colorectal cancer

H. Hollema, R. Hofstra, R. Hofstra, 2000, Genes, chromosomes & cancer.

Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of lynch syndrome

P. Devilee, C. Tops, J. Wijnen, 2012, Human mutation.

Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer

H. Vasen, J. Wijnen, H. Vasen, 1999, Cytogenetic and Genome Research.

Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity

F. Bosman, J. Wijnen, P. Khan, 2005, The Histochemical Journal.

Title Interplay between BRCA 1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

Loris, Fiona, Meindl, 2012 .

Genetic analysis of a breast–ovarian cancer family, with 7 cases of colorectal cancer linked to BRCA1, fails to support a role for BRCA1 in colorectal tumorigenesis

P. Devilee, H. Morreau, C. Cornelisse, 2000, International journal of cancer.

A founder BRCA2 mutation in non‐Afrikaner breast cancer patients of the Western Cape of South Africa

W. Foulkes, N. Hamel, J. Wijnen, 2012, Clinical genetics.

Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ

M. Schilham, A. Cleton-Jansen, W. Jiskoot, 2014, Journal of experimental & clinical cancer research : CR.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer

P. Møller, E. Hovig, S. Nakken, 2022 .

Vector-Alu PCR: a rapid step in mapping cosmids and YACs.

C. Tops, J. Wijnen, C. Breukel, 1990, Nucleic acids research.

Novel MLH1 duplication identified in Colombian families with Lynch syndrome

I. Tomlinson, M. Milá, L. Carvajal-Carmona, 2011, Genetics in Medicine.

Electrophoretic characterization and genetics of human biliverdin reductase (BLVR; EC 1.3.1.24); assignment of BLVR to the p14 → cen region of human chromosome 7 in mouse-human somatic cell hybrids

K. Grzeschik, J. Wijnen, P. Meera Khan, 2004, Biochemical Genetics.

Solid-phase adsorption of antigens for efficient production of antibodies reactive with native and fixed tissue antigens.

W. Dinjens, F. Bosman, J. Wijnen, 1990, Journal of immunological methods.

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

P. Møller, G. Capellá, A. Lindblom, 2013, Gut.

8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome

R. Scott, B. Talseth-Palmer, H. Vasen, 2012, European Journal of Human Genetics.

Gene‐environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing

J. Wijnen, Jae‐Gahb Park, H. Vasen, 1999, International journal of cancer.

Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors

M. Nöthen, M. Kloor, T. Becker, 2012, Familial Cancer.

Paternal duplication of chromosome 5q11.2–5q14 in a male born with craniostenosis, ear tags, kidney dysplasia and several other anomalies

F. Beemer, J. Wijnen, P. Khan, 1993, Human Genetics.

SNP association study in PMS2-associated Lynch syndrome

E. Steyerberg, A. Wagner, T. van Wezel, 2017, Familial Cancer.

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

P. Møller, G. Capellá, S. Tejpar, 2008, Gut.

adenomatous polyposis (FAP) Guidelines for the clinical management of familial

G. Capellá, S. Tejpar, H. Järvinen, 2008 .

Peutz–Jeghers syndrome: a systematic review and recommendations for management

P. Møller, G. Capellá, S. Tejpar, 2010, Gut.

Structure of the bovine eye lens γs-crystallin gene (formerly βs)

W. W. Jong, M. Oldenburg, J. Wijnen, 1989 .

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

R. Nussbaum, D. Steinemann, V. Pankratz, 2014, Breast Cancer Research.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database

Rodney J Scott, John-Paul Plazzer, Finlay Macrae, 2013, Nature Genetics.

Rare variants in XRCC2 as breast cancer susceptibility alleles

F. Couch, J. Benítez, K. Offit, 2012, Journal of Medical Genetics.

Performance of BRCA1/2 mutation prediction models in male breast cancer patients

J. Martens, M. Adank, C. V. van Deurzen, 2018, Clinical genetics.

Variants of Uncertain Significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling

C. V. van Asperen, F. Hogervorst, M. Vreeswijk, 2012, Journal of Medical Genetics.

Bmc Cancer

Leila Mohammadi, Peter Devilee, Hans C van Houwelingen, 2022 .

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

P. Devilee, M. Blok, S. Verhoef, 2009, Breast Cancer Research.

Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)

P. Møller, P. Hutter, W. Foulkes, 2005, Genes, chromosomes & cancer.

The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome

J. Mecklin, H. Järvinen, I. Bernstein, 2008, International journal of cancer.

A review of the genetic background and tumour profiling in familial colorectal cancer.

H. Morreau, T. van Wezel, J. Wijnen, 2012, Mutagenesis.

University of Groningen A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history Garcia,

P. Devilee, A. Ouweland, M. Blok, 2015 .

UvA-DARE ( Digital Academic Repository ) A method to assess the clinical significance of unclassified variants in the BRCA 1 and BRCA 2 genes based on cancer family history

P. Devilee, A. Ouweland, M. Blok, 2009 .

University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch,

F. Couch, B. Bonanni, O. Olopade, 2013 .

Splicing analysis for exonic and intronic mismatch repair gene variants associated with Lynch syndrome confirms high concordance between minigene assays and patient RNA analyses

P. Devilee, C. Tops, J. Wijnen, 2015, Molecular genetics & genomic medicine.

Distinct Patterns of Somatic Mosaicism in the APC Gene in Neoplasms From Patients With Unexplained Adenomatous Polyposis.

W. Dinjens, H. Morreau, T. van Wezel, 2017, Gastroenterology.

Cancer Risks for PMS2-Associated Lynch Syndrome.

Aung Ko Win, M. von Knebel Doeberitz, P. Møller, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Somatic APC mosaicism: an underestimated cause of polyposis coli

E. Bakker, M. Breuning, H. Vasen, 2007, Gut.

Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis

P. Møller, P. Radice, K. Devarajan, 2015, Oncotarget.

Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue.

C. V. van Asperen, T. van Wezel, T. Bosse, 2018, The Journal of molecular diagnostics : JMD.

Genetic modifiers of cancer risk in Lynch syndrome: a review

R. Scott, B. Talseth-Palmer, Desma M. Grice, 2013, Familial Cancer.

Disentangling the Babylonian speech confusion in genetic counseling: An analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic

A. Stiggelbout, C. Asperen, A. Tibben, 2009, Genetics in Medicine.

Detection of mixed chimaerism in flow‐sorted cell subpopulations by PCR‐amplified VNTR markers after allogeneic bone marrow transplantation

H. Tanke, J. Wijnen, M. V. van Tol, 1991, British journal of haematology.

Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.

Julian Peto, Kyriaki Michailidou, Kamila Czene, 2016, Human molecular genetics.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.

C. V. van Noorden, T. Vulliamy, C. J. Pronk-Admiraal, 1999, Blood.

A 10‐Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North‐American kindred

A. Wagner, R. Fodde, P. Franken, 2002, Genes, chromosomes & cancer.

A Founder Mutation of theMSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States

A. Wagner, R. Fodde, P. Franken, 2004 .

A Founder Mutation of the MSH 2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States

A. Wagner, R. Fodde, P. Franken, 2004 .

Multiple Primary Cancer, Including Transitional Cell Carcinoma of the Upper Uroepithelial Tract in a Multigeneration HNPCC Family: Molecular Genetic, Diagnostic, and Management Implications

A. Wagner, J. Knezetic, R. Fodde, 2003, American Journal of Gastroenterology.

TGFBR1*6A may contribute to hereditary colorectal cancer.

A. de la Chapelle, B. Pasche, J. Baron, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.

F. Bosman, G. Griffioen, R. Quadt, 1984, Cancer research.

RNA analysis of cancer predisposing genes in formalin-fixed paraffin-embedded tissue determines aberrant splicing

H. Morreau, T. van Wezel, C. Tops, 2018, European Journal of Human Genetics.

Distribution of adenosine deaminase-complexing protein in murine tissues.

W. Dinjens, F. Bosman, J. Wijnen, 1989, The Journal of biological chemistry.

Familial endometrial cancer in female carriers of MSH6 germline mutations

P. Møller, H. Meijers-Heijboer, R. Hofstra, 1999, Nature Genetics.

Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.

A. Zwinderman, K. Heimdal, P. Møller, 1998, The New England journal of medicine.

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

R. Fodde, J. Mohr, J. Kleibeuker, 1996, Gastroenterology.

Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis

A. Wagner, H. Morreau, T. van Wezel, 2013, Journal of Medical Genetics.

Role of the Oxidative DNA Damage Repair Gene OGG1 in Colorectal Tumorigenesis

V. Moskvina, P. Quirke, P. Propping, 2013 .

Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesis.

V. Moskvina, P. Quirke, P. Propping, 2013, Journal of the National Cancer Institute.

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

P. Møller, H. V. van Houwelingen, G. Kenter, 2004, Gastroenterology.

Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer

H. Meijers-Heijboer, A. Wagner, H. Morreau, 2004, Clinical Cancer Research.

Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.

H. Morreau, R. Fodde, P. Franken, 2003, The American journal of pathology.

Marfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association?

G. Calin, R. Fodde, R. Smits, 1999, European Journal of Human Genetics.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Lara E Sucheston-Campbell, Simon G. Coetzee, Dennis J. Hazelett, 2017, Nature Genetics.

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians

H. Morreau, M. Breuning, H. Vasen, 2006, CA: a cancer journal for clinicians.

The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

W. Chung, F. Couch, O. Olopade, 2021, Genetics in Medicine.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer

J. Klijn, M. Schutte, P. Devilee, 2010, Breast Cancer Research and Treatment.

CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal Cancer

J. Klijn, M. Schutte, H. Meijers-Heijboer, 2008, Clinical Cancer Research.

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.

J. Klijn, A. Hollestelle, M. Schutte, 2003, American journal of human genetics.

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

P. Møller, G. Capellá, J. Mecklin, 2007, Journal of Medical Genetics.

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

W. Chung, R. Nussbaum, D. Steinemann, 2015, PloS one.

Title Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA 1 and BRCA 2 mutation carriers

R. Nussbaum, D. Steinemann, V. Pankratz, 2015 .

Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients

P. Devilee, A. Wagner, H. Morreau, 2016, PloS one.

Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers

P. Devilee, A. Wagner, H. Morreau, 2015, European Journal of Human Genetics.

Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer

H. Morreau, T. van Wezel, M. Ligtenberg, 2014, European Journal of Human Genetics.

Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.

H. Putter, C. van Kesteren, R. Bredius, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome

P. Devilee, C. Asperen, S. Verhoef, 2016, Human mutation.

A cell‐free assay for the functional analysis of variants of the mismatch repair protein MLH1

N. de Wind, H. Morreau, C. Tops, 2010, Human mutation.

A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

Julian Peto, Henry Völzke, Sergi Castellví-Bel, 2008, Nature Genetics.

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Marc Vidal, Dieter Niederacher, Roderic Guigó, 2011, PLoS biology.

Multiple products in the protein truncation test due to alternative splicing in the adenomatous polyposis coli (APC) gene

S. Bala, J. Wijnen, C. Kraus, 1996, Human Genetics.

A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.

A. de la Chapelle, A. Wagner, R. Fodde, 2004, JAMA.

Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis.

R. Fodde, R. B. van der Luijt, G. Griffioen, 1992, Genomics.

DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.

J. Hoffmann, F. Erdkamp, J. Wijnen, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

S. Seal, N. Rahman, D. Noh, 2012, PloS one.

Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2

S. Seal, N. Rahman, D. Noh, 2012 .

Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

P. Møller, G. Capellá, A. Lindblom, 2010, Familial Cancer.

Bias in detection of instability of the (C)8 mononucleotide repeat of MSH6 in tumours from HNPCC patients

H. Morreau, C. Cornelisse, H. Vasen, 2001, Oncogene.

The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.

P. Eilers, H. Morreau, J. Kleibeuker, 2004, Gastroenterology.

Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.

P. Møller, R. Fodde, M. Losekoot, 1997, American journal of human genetics.

Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families.

M. Nelen, W. Bergman, R. Frants, 1989, Genomics.

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

G Rennert, N Weerasooriya, K Offit, 2009, British Journal of Cancer.

q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012 .

MSH2 genomic deletions are a frequent cause of HNPCC

P. Møller, D. Lindhout, H. Vasen, 1998, Nature Genetics.

Value-based healthcare in Lynch syndrome

R. Tollenaar, D. Hommes, C. Asperen, 2013, Familial Cancer.

Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.

R. Houlston, P. Devilee, I. Tomlinson, 2009, Gastroenterology.

RNA-based mutation screening in hereditary nonpolyposis colorectal cancer.

M. Kohonen-Corish, F. Macrae, D. S. St. John, 1996, American journal of human genetics.

Edinburgh Research Explorer The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer

J. Hampe, A. Lindblom, P. Peterlongo, 2018 .

The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer: Genetic Association Study in 18,723 Individuals

J. Hampe, Á. Carracedo, A. Lindblom, 2014, PloS one.

Introduction to molecular and clinical genetics of colorectal cancer syndromes.

C. Tops, J. Wijnen, F. Hes, 2009, Best practice & research. Clinical gastroenterology.

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

K. Czene, P. Hall, V. Pankratz, 2009, Breast Cancer Research and Treatment.

Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16.

A. Cats, R. Fodde, R. Kolodner, 1996, American journal of human genetics.

Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry

J. Kleibeuker, M. Breuning, H. Vasen, 2016, Familial Cancer.

Distribution of adenosine deaminase complexing protein (ADCP) in human tissues.

W. Dinjens, F. Bosman, J. Wijnen, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Identification of HNPCC by Molecular Analysis of Colorectal and Endometrial Tumors

H. Morreau, H. Vasen, A. Bröcker-Vriends, 2004, Disease markers.

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

C Schafmayer, H Campbell, H Brenner, 2009, British Journal of Cancer.

Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.

Julian Peto, Sergi Castellví-Bel, Jean-Baptiste Cazier, 2008, Human molecular genetics.

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

J. Chang-Claude, M. Hoffmeister, H. Völzke, 2013, PloS one.

EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.

L. Aaltonen, P. Møller, R. Houlston, 2003, Cancer research.

Endometrial cancer in four sisters: report of a kindred with presumed cancer family syndrome.

R. Verheijen, H. Vasen, R. Felt‐Bersma, 1994, Gynecologic oncology.

[Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer].

R. Fodde, G. Griffioen, H. Vasen, 1999, Nederlands tijdschrift voor geneeskunde.

Excluding Lynch syndrome in a female patient with metachronous DNA mismatch repair deficient colon- and ovarian cancer

W. Dinjens, H. Morreau, T. van Wezel, 2017, Familial Cancer.

CA repeat polymorphism from YAC JW25 at the D5S318 locus, distal to adenomatous polyposis coli (APC).

R. Fodde, C. Tops, J. Wijnen, 1991, Nucleic acids research.

Spectrum of genetic alterations in Muir‐Torre syndrome is the same as in HNPCC

P. Radice, R. Fodde, G. Cetto, 2004, American journal of medical genetics. Part A.

Genetic counseling in hereditary nonpolyposis colorectal cancer.

H. Vasen, F. Menko, J. Wijnen, 1996, Oncology.

[Genetics of colorectal cancer. II. Hereditary background of sporadic and familial colorectal cancer].

R. Fodde, G. Griffioen, H. Vasen, 1999, Nederlandsch tijdschrift voor geneeskunde.

RNA analysis of cancer predisposing genes in formalin-fixed paraffin-embedded tissue determines aberrant splicing

H. Morreau, T. van Wezel, C. Tops, 2018, European Journal of Human Genetics.

The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family

T. Reinards, A. Wagner, H. Morreau, 2007, Familial Cancer.

Genetic modifiers of cancer risk in Lynch syndrome: a review

R. Scott, B. Talseth-Palmer, Desma M. Grice, 2013, Familial Cancer.

The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded material

H. Morreau, T. van Wezel, C. Tops, 2019, European Journal of Human Genetics.

Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chromosome 5q21-q22

G. Griffioen, H. Vasen, C. Tops, 1988, Human Genetics.

Glutathione S-transferase activity in human fetal and adult tissues.

H. Mukhtar, D. Breimer, J. Wijnen, 1981, Pharmacology.

SESSION 2 Multiplex targeted long amplicon sequencing method for Cyp 2 d 6 genotyping using the PacBio RSII

S. Anvar, H. Buermans, M. Losekoot, 2015 .

A new deletion polymorphism at D5S71 raises the linkage information on adenomatous polyposis coli: implications for presymptomatic diagnosis

F. Nagengast, G. Griffioen, C. Lamers, 1991, Human Genetics.

Linkage Studies on Familial Adenomatous Polyposis in the Netherlands

G. Griffioen, C. Lamers, H. Vasen, 1990 .

G6PD Punjab, a dialysis sensitive variant of human glucose-6-phosphate dehydrogenase

J. Wijnen, P. Khan, C. Verma, 1987, Journal of Genetics.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

D. Bishop, R. Scott, D. Evans, 2013 .

An evaluation of the integration of non-traditional learning tools into a community based breast and cervical cancer education program: The witness project of Buffalo

Takuji Tanaka, H. V. van Houwelingen, P. Devilee, 2003, BMC Cancer.

Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis

H. Morreau, M. Weiss, M. Breuning, 2007, Clinical genetics.

SNP association study in PMS2-associated Lynch syndrome

E. Steyerberg, A. Wagner, C. Tops, 2017, Familial Cancer.

The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients

R. Scott, A. Spigelman, B. Talseth-Palmer, 2013, Hereditary cancer in clinical practice.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

D. Bishop, A. Lindblom, J. Lubiński, 2011 .

Human α-globin maps to pter-p13.3 in chromosome 16 distal to PGP

P. Pearson, M. Breuning, J. Wijnen, 1987, Human Genetics.

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Communications.

Histological subclassification of the nodular sclerotic type of Hodgkin's disease.

L. Vrints, J. Wijnen, W. Breed, 1988, Netherlands Journal of Medicine.

Common variants at 12 p 11 , 12 q 24 , 9 p 21 , 9 q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, David Evans, 2017 .

University of Groningen Identification of a BRCA 2-Specific Modifier Locus at 6 p 24 Related to Breast Cancer

D. Altshuler, V. Pankratz, F. Couch, 2017 .

Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

F. Couch, O. Olopade, T. Rebbeck, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers

O. Olopade, T. Rebbeck, R. Eeles, 2011 .

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer

David Evans, A. Lindblom, J. Lubiński, 2016 .

A genetic variant in telomerase reverse transcriptase (TERT) modifies cancer risk in Lynch syndrome patients harbouring pathogenic MSH2 variants

G. Capellá, J. Lubiński, B. Talseth-Palmer, 2021, Scientific Reports.

The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome

J. Mecklin, H. Järvinen, I. Bernstein, 2008, International journal of cancer.

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.

P. Møller, A. Lindblom, I. Bernstein, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Leiden open variation database of the MUTYH gene

P. Devilee, F. Fostira, I. Fokkema, 2010, Human mutation.

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

P. Møller, G. Capellá, S. Tejpar, 2008, Gut.

Peutz–Jeghers syndrome: a systematic review and recommendations for management

S. Tejpar, H. Järvinen, J. Burn, 2010, Gut.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Bonanni, J. Benítez, 2009, Human molecular genetics.

Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

B. Bonanni, O. Olopade, B. Karlan, 2012 .

Increased frequency of 20q gain and copy‐neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas

H. Morreau, T. van Wezel, T. Caldés, 2012, International journal of cancer.

G6PD VARIATION IN INDIA1

J. Wijnen, P. Khan, 1986 .

Seven New Mutations in hMSH2, an HNPCC Gene, Identified by Denaturing Gradient-Gel Electrophoresis

Inge, D. Lindhout, G. Griffioen, 2007 .

Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

H. Morreau, T. van Wezel, M. M. van der Klauw, 2017, British Journal of Cancer.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

A. Whittemore, F. Couch, B. Bonanni, 2015 .

The complexity of screening PMS2 in DNA isolated from formalin-fixed paraffin-embedded material

H. Morreau, T. van Wezel, C. Tops, 2019, European Journal of Human Genetics.

Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)

G. Capellá, C. Engel, J. Burn, 2007, Journal of Medical Genetics.